[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100498660":3},{"organization":4,"armGroups":7,"interventions":32,"overallOfficials":43,"centralContacts":54,"locations":59,"responsibleParty":109,"collaborators":112,"id":116,"slug":38,"hasResults":117,"nctId":118,"briefTitle":119,"officialTitle":119,"acronym":120,"eligibilityCriteria":121,"healthyVolunteers":117,"sex":122,"minAge":123,"maxAge":38,"enrollmentInfo":124,"targetDuration":38,"studyType":127,"phases":128,"briefSummary":130,"conditions":131,"keywords":38,"overallStatus":62,"whyStopped":38,"lastUpdateSubmitDate":133,"lastUpdatePostDateStruct":134,"startDateStruct":137,"completionDateStruct":139,"leadSponsor":141,"locationsCount":142},{"fullName":5,"class":6},"AdventHealth Translational Research Institute","OTHER",[8,14,20,24,28],{"label":9,"type":10,"description":11,"interventionNames":12},"Attention control","SHAM_COMPARATOR","Static stretching",[13],"Behavioral: Progressive stretching",{"label":15,"type":16,"description":17,"interventionNames":18},"75 min\u002Fwk aerobic exercise","EXPERIMENTAL","Aerobic exercise at a dose of 75 minutes per week",[19],"Behavioral: Aerobic exercise",{"label":21,"type":16,"description":22,"interventionNames":23},"150 min\u002Fwk aerobic exercise","Aerobic exercise at a dose of 150 minutes per week",[19],{"label":25,"type":16,"description":26,"interventionNames":27},"225 min\u002Fwk aerobic exercise","Aerobic exercise at a dose of 225 minutes per week",[19],{"label":29,"type":16,"description":30,"interventionNames":31},"300 min\u002Fwk aerobic exercise","Aerobic exercise at a dose of 300 minutes per week",[19],[33,39],{"type":34,"name":35,"description":36,"armGroupLabels":37,"otherNames":38},"BEHAVIORAL","Aerobic exercise","Moderate- to vigorous-intensity aerobic exercise",[21,25,29,15],null,{"type":34,"name":40,"description":41,"armGroupLabels":42,"otherNames":38},"Progressive stretching","Static stretching of eight major muscle groups",[9],[44,48,51],{"name":45,"affiliation":46,"role":47},"Justin C. Brown, Ph.D.","AdventHealth","PRINCIPAL_INVESTIGATOR",{"name":49,"affiliation":50,"role":47},"Jeffrey A. Meyerhardt, M.D., M.P.H.","Dana-Farber Cancer Institute",{"name":52,"affiliation":53,"role":47},"Bette J. Caan, Dr.P.H.","Kaiser Permanente",[55],{"name":45,"role":56,"phone":57,"phoneExt":38,"email":58},"CONTACT","4076095000","Justin.Brown4@AdventHealth.com",[60,79,94],{"facility":61,"status":62,"city":63,"state":64,"zip":65,"country":66,"cosmosGeoPoint":67,"geoPoint":72,"contacts":73},"Kaiser Permanente Northern California","RECRUITING","Oakland","California","94612","United States",{"type":68,"coordinates":69},"Point",[70,71],-122.2708,37.80437,{"lat":71,"lon":70},[74,77],{"name":75,"role":56,"phone":38,"phoneExt":38,"email":76},"Michelle Ross","Michelle.C.Ross@kp.org",{"name":78,"role":47,"phone":38,"phoneExt":38,"email":38},"Bette J Caan, Dr.P.H.",{"facility":46,"status":62,"city":80,"state":81,"zip":82,"country":66,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Orlando","Florida","32804",{"type":68,"coordinates":84},[85,86],-81.37924,28.53834,{"lat":86,"lon":85},[89,92],{"name":90,"role":56,"phone":38,"phoneExt":38,"email":91},"Abigail Tice, Ph.D.","Abigail.Tice@AdventHealth.com",{"name":93,"role":47,"phone":38,"phoneExt":38,"email":38},"Justin Brown, Ph.D.",{"facility":50,"status":62,"city":95,"state":96,"zip":97,"country":66,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"Boston","Massachusetts","02215",{"type":68,"coordinates":99},[100,101],-71.05977,42.35843,{"lat":101,"lon":100},[104,107],{"name":105,"role":56,"phone":38,"phoneExt":38,"email":106},"Christine Lu, M.P.H.","christine_lu@dfci.harvard.edu",{"name":108,"role":47,"phone":38,"phoneExt":38,"email":38},"Jeffrey A Meyerhardt, M.D.",{"type":47,"investigatorFullName":110,"investigatorTitle":111,"investigatorAffiliation":5,"oldNameTitle":38,"oldOrganization":38},"Justin Brown","Senior Investigator",[113],{"name":114,"class":115},"National Cancer Institute (NCI)","NIH","100498660",false,"NCT05773144","Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer","ACTION","Inclusion Criteria:\n\n* Age ≥18 years\n* Histologically confirmed stage II or III colon cancer\n* Completed surgical resection with curative intent\n* Plan to initiate chemotherapy\n* Engage in \\\u003C60 minutes per week of moderate- to vigorous-intensity structured aerobic exercise\n* No planned major surgery during the study period\n* Readiness to exercise, as determined by a modified version of the Physical Activity Readiness Questionnaire\n* Can walk 400 meters\n* Can read and speak English\n* Ability to provide written informed consent\n* Provide written approval by qualified healthcare professional\n* Willing to be randomized\n\nExclusion Criteria:\n\n* Evidence of metastatic colon cancer\n* Concurrently actively treated other (non-colon) cancer\n* Currently pregnant, breastfeeding, or planning to become pregnant within the next 24 weeks\n* Currently participating in another study with competing outcomes\n* Any other condition that, in the opinion of the investigator, would preclude participation or successful compliance with the protocol\n* Any other situation that, in the opinion of the investigator, would negatively impact subject safety or successful compliance with the protocol","ALL","18 Years",{"count":125,"type":126},219,"ESTIMATED","INTERVENTIONAL",[129],"NA","To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.",[132],"Colonic Neoplasms","2026-01-05",{"date":135,"type":136},"2026-01-07","ACTUAL",{"date":138,"type":136},"2023-06-01",{"date":140,"type":126},"2027-05-01",{"name":5,"class":6},3]